Skip to yearly menu bar Skip to main content


Discussion
in
Workshop: New Frontiers of AI for Drug Discovery and Development

Roundtable Discussion


Abstract:

Karen Sayal (GSK): The Opportunities and Challenges of Integrating ML into Clinical Trials

Bülent Kiziltan (Novartis): From Drug Discovery to Drug Design: AI-driven Generative Chemistry

Haoda Fu (Eli Lilly): AI/ML Based De Novo Design for Biologics

Quanquan Gu (UCLA/ByteDance): TBA

Chat is not available.